Juan Xia Selected Research

Proto-Oncogene Proteins c-vav

1/2022

Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Xia Research Topics

Disease

36	Neoplasms (Cancer) 07/2022 - 04/2010
25	Squamous Cell Carcinoma of Head and Neck 07/2022 - 01/2014
18	Chronic Hepatitis B 04/2022 - 02/2011
13	Fibrosis (Cirrhosis) 04/2022 - 01/2016
12	Inflammation (Inflammations) 04/2022 - 05/2011
12	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2016
11	Carcinogenesis 07/2021 - 06/2009
10	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2011
5	Oral Lichen Planus 07/2021 - 07/2006
5	Infections 01/2020 - 07/2014
5	Hepatitis 01/2020 - 09/2015
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 04/2014
4	Mouth Neoplasms (Oral Cancer) 04/2018 - 07/2013
3	Hypertension (High Blood Pressure) 09/2022 - 01/2021
3	Wounds and Injuries (Trauma) 01/2022 - 05/2011
3	Obesity 10/2021 - 03/2017
3	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 04/2010
3	Carcinoma (Carcinomatosis) 03/2018 - 07/2009
3	Burning Mouth Syndrome (Syndrome, Burning Mouth) 01/2007 - 03/2003
3	Pain (Aches) 01/2007 - 03/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2021
2	Fatigue 07/2019 - 01/2018
2	Glossitis 09/2011 - 05/2011
1	Heart Failure 05/2022
1	Meningeal Tuberculosis (Tuberculous Meningitis) 02/2022
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Lactic Acidosis 02/2022
1	Persistent Infection 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Hepatitis B 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Pneumonia (Pneumonitis) 12/2021
1	Alcoholic Fatty Liver 12/2021
1	Abscess 12/2021
1	Endophthalmitis (Ophthalmia) 12/2021
1	Bacteremia 12/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2009
13	Hepatitis B e AntigensIBA 04/2022 - 02/2011
8	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2017
7	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2017
6	Biological ProductsIBA 01/2022 - 05/2009
6	LigandsIBA 01/2022 - 04/2011
6	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2011
6	Pharmaceutical PreparationsIBA 12/2021 - 04/2014
6	Messenger RNA (mRNA)IBA 10/2021 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2009
5	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 04/2022 - 01/2017
4	ChemokinesIBA 01/2022 - 04/2011
4	Chemokine ReceptorsIBA 01/2022 - 01/2011
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 09/2015
4	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2018 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2022
3	Long Noncoding RNAIBA 01/2022 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2014
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2011
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 10/2003
3	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 01/2019 - 07/2009
3	CC ChemokinesIBA 02/2018 - 03/2016
3	dihydromyricetinIBA 10/2014 - 04/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2022 - 02/2018
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2021 - 07/2009
2	sapanisertibIBA 01/2021 - 10/2019
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 10/2019
2	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 01/2019
2	domatinostatIBA 10/2019 - 01/2019
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2019 - 01/2016
2	CurcuminIBA 10/2018 - 01/2016
2	entecavir FDA Link 11/2017 - 02/2011
2	ResveratrolIBA 04/2015 - 10/2014
2	FlavonoidsIBA 04/2014 - 04/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2013 - 12/2011
2	Connexin 43 (Connexin43)IBA 07/2013 - 06/2009
2	ConnexinsIBA 07/2013 - 06/2009
1	Air Pollutants (Pollutants, Air)IBA 09/2022
1	vericiguatIBA 05/2022
1	Soluble Guanylyl CyclaseIBA 05/2022
1	Transaminases (Aminotransferases)IBA 04/2022
1	Linezolid (Zyvox)FDA Link 02/2022
1	Monomeric GTP-Binding ProteinsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Proto-Oncogene Proteins c-vavIBA 01/2022
1	tazemetostatIBA 01/2022
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2022
1	Succinic Acid (Succinate)IBA 12/2021
1	biapenem (L 627)IBA 12/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021
1	LuciferasesIBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2021
1	AntibodiesIBA 08/2021

Therapy/Procedure

13	Therapeutics 07/2022 - 03/2003
4	Immunotherapy 01/2022 - 01/2019
2	Radiotherapy 09/2011 - 05/2011
1	Continuous Renal Replacement Therapy 02/2022
1	Catheters 12/2021
1	Pancreaticoduodenectomy 12/2021
1	Parenteral Nutrition 12/2021